(Q31112095)

28 June 2017

title

Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006. (English)

1 reference

28 June 2017

4

Harmony P Garges

1 reference

28 June 2017

Jacob P Lalezari

1

1 reference

28 June 2017

Douglas J Ward

series ordinal

2

1 reference

28 June 2017

Susan A Tomkins

series ordinal

3

1 reference

28 June 2017

language of work or name

English

0 references

publication date

8 May 2007

1 reference

Journal of Antimicrobial Chemotherapy

28 June 2017

published in

1 reference

28 June 2017

volume

60

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

170-174

1 reference

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM122

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM122

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM122

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM122

Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM122

21 January 2018

Identifiers

DOI

10.1093/JAC/DKM122

1 reference

28 June 2017

1 reference